Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001266457 | SCV001444632 | uncertain significance | Inborn genetic diseases | 2018-04-26 | criteria provided, single submitter | clinical testing | The p.V1282F variant (also known as c.3844G>T), located in coding exon 19 of the SCN2A gene, results from a G to T substitution at nucleotide position 3844. The valine at codon 1282 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005014319 | SCV005650060 | uncertain significance | Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11; Episodic ataxia, type 9 | 2024-04-25 | criteria provided, single submitter | clinical testing |